| Issue |
Vis Cancer Med
Volume 4, 2023
|
|
|---|---|---|
| Article Number | 6 | |
| Number of page(s) | 5 | |
| DOI | https://doi.org/10.1051/vcm/2023002 | |
| Published online | 31 May 2023 | |
Supplementary material
Video 1: Semaphorin 4C, CA125, and CA153 expression in breast cancer tumor microenvironment. This video shows the expression of semaphorin 4C, CA125, and CA153 in four molecular subtypes of breast cancer including luminal A, luminal B, human epidermal growth factor receptor 2 (HER2)-positive, and triple-negative breast cancer.
Download Video: Formats: mp4 (3.6 MB) | webm (2.2 MB) | ogg (8.9 MB) | Original mp4 (3.6 MB)
Video 2: Semaphorin 4C accelerates disease progression and enables disease detection in breast cancer. This video presents the biological processes by which semaphorin 4C accelerates breast cancer progression and enables breast cancer detection based on two of our previous reports [7, 13]. The icons in the video were created with Biorender.com.
Download Video: Formats: mp4 (25.5 MB) | webm (1.1 MB) | ogg (16.0 MB) | Original mp4 (25.5 MB)
© The Authors, published by EDP Sciences, 2023
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.